Startup | March 27, 2025
Mila Beaute raises $2.16 million in pre-series A round led by Rukam Capital
The freshly infused capital will primarily be deployed towards expansion and research & development
The freshly infused capital will primarily be deployed towards expansion and research & development
EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults
The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
This program, titled "Food Supplementation and Capacity Building Support for Improved Nutrition in Malinao, Aklan," aligns with the country’s national health
Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
Prior to joining Neuland, Deshmukh held several key positions at Cipla
The company has also launched its first three 24*7 pharmacy stores via COCO model in Bengaluru
Subscribe To Our Newsletter & Stay Updated
